Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Advanced Biomed Inc. (ADVB : NSDQ)

• Company Description    Advanced Biomed Inc. is a biotechnology company focused on early screening and detection, diagnosis and staging and treatment of cancer. Advanced Biomed Inc. is based in Tainan, Taiwan. Number of Employees: 40

• Price / Volume Information    Yesterday's Closing Price: $0.79 Daily Weekly Monthly 20 Day Moving Average: 157,628 shares Shares Outstanding: 21.64 (millions) Market Capitalization: $16.99 (millions) Beta: 52 Week High: $4.10 52 Week Low: $0.56 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -18.05% -21.11% 12 Week -56.62% -63.51% Year To Date % %

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 122 EAST 42ND STREET 18TH FLOOR - NEW YORK,NY 10168 USA ph: 886-6312-1716 fax: - alan@advanbiomed.com http://www.advanbiomed.com

• General Corporate Information    Officers Yi Lu - Chief Executive Officer and Chairman Mingze Yin - Chief Financial Officer Hung To Pau - Director Jing Zhang - Director Cheang I Kei - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 00752P104 SIC: 8071 Fiscal Year Fiscal Year End: June Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/21/25 Share - Related Items Shares Outstanding: 21.64 Most Recent Split Date: (:1) Beta: Market Capitalization: $16.99 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/21/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 4.11 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -75.00% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - - ROA 06/30/25 - - 03/31/25 - - 12/31/24 - - Current Ratio 06/30/25 - - 03/31/25 - 1.88 12/31/24 - - Quick Ratio 06/30/25 - - 03/31/25 - 1.88 12/31/24 - - Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Book Value 06/30/25 - - 03/31/25 - 0.19 12/31/24 - - Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - 0.00 12/31/24 - - Debt-to-Capital 06/30/25 - - 03/31/25 - 0.00 12/31/24 - -

Powered by Zacks Investment Research ©